The pharma major fell more than 5 per cent in a week which triggered the breakdown from a 50-point range where Rs 700 acted as a stiff resistance while levels of Rs 658-660 and above acted as strong support. The stock closed at Rs 652 on 26 August 2022.
Cut the noise, back conviction: Madhusudan Kela on investing through volatility
Market veteran Madhusudan Kela advises investors to focus on wealth creation and ignore market noise, viewing volatility as an opportunity. He emphasizes the importance of
February 13, 2026